首页 > 最新文献

Yonago acta medica最新文献

英文 中文
Erratum for Yamanaka et al., "Parental Issues and Support Needs in Selective Mutism in Japan: A Quantitative Content Analysis". Yamanaka等人,“日本选择性缄默症的父母问题和支持需求:定量内容分析”的勘误。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-02-21 eCollection Date: 2024-11-01 DOI: 10.33160/yam.2024.11.010
Tomohisa Yamanaka, Honami Koyama, Masahiko Inoue

[This corrects the article DOI: 10.33160/yam.2024.11.004.].

[这更正了文章DOI: 10.33160/yam.2024.11.004.]。
{"title":"Erratum for Yamanaka et al., \"Parental Issues and Support Needs in Selective Mutism in Japan: A Quantitative Content Analysis\".","authors":"Tomohisa Yamanaka, Honami Koyama, Masahiko Inoue","doi":"10.33160/yam.2024.11.010","DOIUrl":"https://doi.org/10.33160/yam.2024.11.010","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.33160/yam.2024.11.004.].</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"67 4","pages":"363"},"PeriodicalIF":0.9,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11851327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143504577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Rapidly Progressing Urothelial Carcinoma Arising After Living Donor Kidney Transplantation Treated with Chemotherapy and Immune Checkpoint Inhibitors. 化疗和免疫检查点抑制剂治疗活体肾移植后发生进展迅速的尿路上皮癌1例。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-02-15 eCollection Date: 2025-02-01 DOI: 10.33160/yam.2025.02.009
Katsuya Hikita, Ryoma Nishikawa, Sosuke Taniguchi, Yukari Mae, Takuji Iyama, Tomoaki Takata, Shuichi Morizane, Masashi Honda, Atsushi Takenaka

The incidence of malignancy following long-term immunosuppression is increased in organ transplant recipients. We report a case of a patient with right ureteral and bladder cancer after living donor kidney transplantation for chronic glomerulonephritis and who was administered chemotherapy and immune checkpoint inhibitors. A 75-year-old male, 20 years post-living donor kidney transplantation for chronic glomerulonephritis, presented with malignant cells in urinary cytology. Despite initial treatments including transurethral resection of the bladder tumor, the tumor progressed to high-grade urothelial carcinoma. Computerized tomography results showed a right ureteral tumor and multiple lymph node metastases. Therefore, the patient underwent systemic chemotherapy with four cycles of gemcitabine and carboplatin. Pembrolizumab was administered due to rapid cancer progression; however, the cancer progressed further, and the patient was treated palliatively. The patient was treated with an immune checkpoint inhibitor with a reduced dose of immunosuppressive drugs with no rejection during the treatment course.

器官移植受者长期免疫抑制后恶性肿瘤的发生率增高。我们报告一例慢性肾小球肾炎活体肾移植后右输尿管和膀胱癌患者,并给予化疗和免疫检查点抑制剂。75岁男性,慢性肾小球肾炎活体肾移植后20年,尿细胞学检查显示有恶性细胞。尽管最初的治疗包括经尿道膀胱肿瘤切除术,但肿瘤进展为高级别尿路上皮癌。计算机断层扫描结果显示右侧输尿管肿瘤及多发淋巴结转移。因此,患者接受了4个周期的吉西他滨和卡铂的全身化疗。由于癌症进展迅速,给予Pembrolizumab;然而,癌症进一步发展,病人接受了姑息治疗。患者在治疗过程中使用免疫检查点抑制剂和减少剂量的免疫抑制药物治疗,无排斥反应。
{"title":"A Case of Rapidly Progressing Urothelial Carcinoma Arising After Living Donor Kidney Transplantation Treated with Chemotherapy and Immune Checkpoint Inhibitors.","authors":"Katsuya Hikita, Ryoma Nishikawa, Sosuke Taniguchi, Yukari Mae, Takuji Iyama, Tomoaki Takata, Shuichi Morizane, Masashi Honda, Atsushi Takenaka","doi":"10.33160/yam.2025.02.009","DOIUrl":"10.33160/yam.2025.02.009","url":null,"abstract":"<p><p>The incidence of malignancy following long-term immunosuppression is increased in organ transplant recipients. We report a case of a patient with right ureteral and bladder cancer after living donor kidney transplantation for chronic glomerulonephritis and who was administered chemotherapy and immune checkpoint inhibitors. A 75-year-old male, 20 years post-living donor kidney transplantation for chronic glomerulonephritis, presented with malignant cells in urinary cytology. Despite initial treatments including transurethral resection of the bladder tumor, the tumor progressed to high-grade urothelial carcinoma. Computerized tomography results showed a right ureteral tumor and multiple lymph node metastases. Therefore, the patient underwent systemic chemotherapy with four cycles of gemcitabine and carboplatin. Pembrolizumab was administered due to rapid cancer progression; however, the cancer progressed further, and the patient was treated palliatively. The patient was treated with an immune checkpoint inhibitor with a reduced dose of immunosuppressive drugs with no rejection during the treatment course.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 1","pages":"75-78"},"PeriodicalIF":0.9,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11831043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Juvenile Trabecular Ossifying Fibroma Arising from the Maxilla in a 2-Year-Old Child. 2岁儿童上颌骨发生幼年小梁骨化性纤维瘤1例。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-02-14 eCollection Date: 2025-02-01 DOI: 10.33160/yam.2025.02.008
Makoto Kawasaki, Rieko Doi, Nobuyuki Fuji, Takayuki Tamura, Isamu Kodani

An ossifying fibroma is a fibroosseous lesion from the maxilla and mandible. Its histopathological subtypes include juvenile trabecular ossifying fibroma (JTOF) and juvenile psammomatoid ossifying fibroma. It commonly affects young individuals and is invasive in nature. A 2-year-old girl with a 2-week history of swelling in the left infraorbital region and a reduced opening of the left eye was referred to our department. Clinical examination revealed a diffuse bone-like swelling extending from the left infraorbital region to the left buccal region. Computed tomography revealed a well-defined 2-cm lesion, and magnetic resonance imaging revealed moderate-to-high signal intensity on T2-weighted imaging. A definitive diagnosis could not be arrived at based solely on imaging findings. A biopsy was initially planned; however, the tumor was extracted because it was relatively easy to separate from the surrounding bone. Histological findings showed fascicular and spiral hyperplasia of the tumor cells containing spindle nuclei and cytoplasm. Fibroma-like stroma, immature chondrocytes, and mature trabecular osteogenesis are also observed. Osteoblast-like or partially chondrocytic sequences were observed at the margins of hard tissue. Thus, a definitive diagnosis of JTOF was established. Although the tumor was extracted only in the present case, JTOF has a high recurrence rate; thus, resection of the surrounding bone is recommended following a definitive diagnosis. In this case, the period from onset to surgery was short, and early treatment allowed the tumor to be removed before it invaded the surrounding bone; therefore, extraction alone prevented recurrence. It can be distinguished from fibrous dysplasia, which has similar pathological findings, based on the observation of osteoblast-like structures at the edge of the trabecular bone. Moreover, the negative guanine nucleotide-binding protein alpha-stimulating activity of polypeptide 1 further confirmed JTOF. No signs of recurrence were observed in this case at 11 years and 9 months postoperatively.

骨化纤维瘤是一种来自上颌骨和下颌骨的纤维骨性病变。其组织病理学亚型包括幼年型小梁骨化纤维瘤(JTOF)和幼年型沙沫样骨化纤维瘤。它通常影响年轻人,具有侵袭性。一名2岁女童,左眶下区肿胀2周,左眼开口缩小,被转介至我科。临床检查发现弥漫性骨样肿胀,从左侧眶下区延伸至左侧颊区。计算机断层扫描显示明确的2厘米病变,磁共振成像显示t2加权成像中至高信号强度。一个明确的诊断不能仅仅基于影像学发现。最初计划进行活检;然而,由于肿瘤相对容易与周围骨骼分离,因此我们将其取出。组织学发现肿瘤细胞呈束状和螺旋状增生,含有梭形核和细胞质。纤维瘤样基质、未成熟软骨细胞和成熟小梁成骨也被观察到。硬组织边缘可见成骨细胞样或部分软骨细胞序列。因此,确定了JTOF的明确诊断。虽然本例仅切除肿瘤,但JTOF复发率高;因此,在明确诊断后,建议切除周围的骨。在这种情况下,从发病到手术的时间很短,早期治疗可以在肿瘤侵犯周围骨骼之前将其切除;因此,单纯拔牙可预防复发。通过观察骨小梁边缘的成骨细胞样结构,可将其与具有相似病理表现的纤维性发育不良区分开来。此外,多肽1的负鸟嘌呤核苷酸结合蛋白α刺激活性进一步证实了JTOF。该病例术后11年9个月无复发迹象。
{"title":"A Case of Juvenile Trabecular Ossifying Fibroma Arising from the Maxilla in a 2-Year-Old Child.","authors":"Makoto Kawasaki, Rieko Doi, Nobuyuki Fuji, Takayuki Tamura, Isamu Kodani","doi":"10.33160/yam.2025.02.008","DOIUrl":"10.33160/yam.2025.02.008","url":null,"abstract":"<p><p>An ossifying fibroma is a fibroosseous lesion from the maxilla and mandible. Its histopathological subtypes include juvenile trabecular ossifying fibroma (JTOF) and juvenile psammomatoid ossifying fibroma. It commonly affects young individuals and is invasive in nature. A 2-year-old girl with a 2-week history of swelling in the left infraorbital region and a reduced opening of the left eye was referred to our department. Clinical examination revealed a diffuse bone-like swelling extending from the left infraorbital region to the left buccal region. Computed tomography revealed a well-defined 2-cm lesion, and magnetic resonance imaging revealed moderate-to-high signal intensity on T2-weighted imaging. A definitive diagnosis could not be arrived at based solely on imaging findings. A biopsy was initially planned; however, the tumor was extracted because it was relatively easy to separate from the surrounding bone. Histological findings showed fascicular and spiral hyperplasia of the tumor cells containing spindle nuclei and cytoplasm. Fibroma-like stroma, immature chondrocytes, and mature trabecular osteogenesis are also observed. Osteoblast-like or partially chondrocytic sequences were observed at the margins of hard tissue. Thus, a definitive diagnosis of JTOF was established. Although the tumor was extracted only in the present case, JTOF has a high recurrence rate; thus, resection of the surrounding bone is recommended following a definitive diagnosis. In this case, the period from onset to surgery was short, and early treatment allowed the tumor to be removed before it invaded the surrounding bone; therefore, extraction alone prevented recurrence. It can be distinguished from fibrous dysplasia, which has similar pathological findings, based on the observation of osteoblast-like structures at the edge of the trabecular bone. Moreover, the negative guanine nucleotide-binding protein alpha-stimulating activity of polypeptide 1 further confirmed JTOF. No signs of recurrence were observed in this case at 11 years and 9 months postoperatively.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 1","pages":"68-74"},"PeriodicalIF":0.9,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11831040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Literacy and Related Factors in Perioperative Patients: A Cross-Sectional Descriptive Study. 围手术期患者健康素养及其相关因素:一项横断面描述性研究。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-02-05 eCollection Date: 2025-02-01 DOI: 10.33160/yam.2025.02.004
Yoshimi Noguchi, Chika Tanimura, Keiko Oba, Hideyuki Kataoka

Background: Perioperative patient health literacy influences postoperative recovery and self-management. We conducted a cross-sectional study to determine perioperative patient health literacy levels and associated factors.

Methods: From August 2021 to January 2022, 187 patients undergoing surgery at an acute care hospital completed a self-administered questionnaire, based on the Functional, Communicative and Critical Health Literacy (FCCHL) scale, to assess health literacy and related factors. Multiple regression analysis was conducted to identify factors associated with health literacy.

Results: Out of 316 surveyed patients, 187 were included in the analysis. Over 70% of perioperative patients in this study were classified as having limited health literacy according to the FCCHL scale. These patients exhibited low communicative and critical health literacy. Factors significantly associated with patients' total health literacy scores included age, knowledge about diseases, education level, use of media about health and disease, and generalized self-efficacy.

Conclusion: Healthcare providers should recognize that perioperative patients generally possess low health literacy. Understanding factors influencing individual health literacy levels is essential to provide tailored support in the perioperative patient.

背景:围手术期患者健康素养影响术后恢复和自我管理。我们进行了一项横断面研究,以确定围手术期患者的健康素养水平和相关因素。方法:从2021年8月至2022年1月,187例在某急症护理医院接受手术的患者完成了一份基于功能、交际和关键健康素养(FCCHL)量表的自填问卷,评估健康素养及其相关因素。进行多元回归分析以确定与健康素养相关的因素。结果:在316例接受调查的患者中,187例纳入分析。根据FCCHL量表,本研究中超过70%的围手术期患者被归类为健康素养有限。这些患者表现出低沟通和关键健康素养。与患者健康素养总分显著相关的因素包括年龄、疾病知识、受教育程度、健康与疾病相关媒体使用情况和广义自我效能感。结论:卫生保健提供者应认识到围手术期患者普遍具有较低的健康素养。了解影响个体健康素养水平的因素对于为围手术期患者提供量身定制的支持至关重要。
{"title":"Health Literacy and Related Factors in Perioperative Patients: A Cross-Sectional Descriptive Study.","authors":"Yoshimi Noguchi, Chika Tanimura, Keiko Oba, Hideyuki Kataoka","doi":"10.33160/yam.2025.02.004","DOIUrl":"10.33160/yam.2025.02.004","url":null,"abstract":"<p><strong>Background: </strong>Perioperative patient health literacy influences postoperative recovery and self-management. We conducted a cross-sectional study to determine perioperative patient health literacy levels and associated factors.</p><p><strong>Methods: </strong>From August 2021 to January 2022, 187 patients undergoing surgery at an acute care hospital completed a self-administered questionnaire, based on the Functional, Communicative and Critical Health Literacy (FCCHL) scale, to assess health literacy and related factors. Multiple regression analysis was conducted to identify factors associated with health literacy.</p><p><strong>Results: </strong>Out of 316 surveyed patients, 187 were included in the analysis. Over 70% of perioperative patients in this study were classified as having limited health literacy according to the FCCHL scale. These patients exhibited low communicative and critical health literacy. Factors significantly associated with patients' total health literacy scores included age, knowledge about diseases, education level, use of media about health and disease, and generalized self-efficacy.</p><p><strong>Conclusion: </strong>Healthcare providers should recognize that perioperative patients generally possess low health literacy. Understanding factors influencing individual health literacy levels is essential to provide tailored support in the perioperative patient.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 1","pages":"34-44"},"PeriodicalIF":0.9,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11831036/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimal Clinically Important Difference in the Brief Assessment of Cognition in Schizophrenia-Japanese Version Composite Score: A Single-Center Preliminary Study. 精神分裂症-日本版综合评分简短认知评估的微小临床重要差异:单中心初步研究。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-25 eCollection Date: 2025-02-01 DOI: 10.33160/yam.2025.02.005
Ryo Oya, Masaki Fujiwara, Yuto Yamada, Tsuyoshi Etoh, Seiji Katayama, Masatoshi Inagaki

Background: Cognitive dysfunction is a major symptom in schizophrenia associated with social skills. It has been reported that cognitive rehabilitation can improve cognitive dysfunction. The Brief Assessment of Cognition in Schizophrenia-Japanese version (BACS-J) is often used as an outcome measure to assess the effectiveness of cognitive rehabilitation. However, the minimal clinically important difference (MCID) in the BACS-J composite score has not been reported. Therefore, we conducted this study to calculate a preliminary MCID in the BACS-J composite score and confirm the feasibility of retrospective data collection and analysis for future large-scale studies.

Methods: The medical records of patients with schizophrenia who underwent cognitive rehabilitation were retrospectively surveyed. BACS-J data were collected at the beginning and end of the cognitive rehabilitation, and Clinical Global Impression-Improvement (CGI-I) data obtained at the end of the cognitive rehabilitation were evaluated retrospectively. To calculate the MCID in the BACS-J composite score using distribution-based methods, the standard error of measurement was calculated as a characteristic of the scale itself. To calculate the MCID using anchor-based methods, the mean change in BACS-J score corresponding to "minimally improved" on the CGI-I was determined.

Results: Twenty-eight patients were included in this study, and BACS-J data were collected from all patients. The CGI-I was completed by 11 patients, 3 of whom showed "minimally improved" according to their CGI scores. Distribution-based methods applied to the data of 28 patients revealed an MCID of 0.735 for the BACS-J composite score. Anchor-based methods were ultimately not applied because the sample size was insufficient.

Conclusion: This study confirmed that CGI and BACS-J data can be collected and analyzed retrospectively. According to distribution-based methods, an increase of approximately 0.7 in the BACS-J composite score can be considered clinically meaningful. Future studies with larger sample sizes using both calculation methods could provide more accurate MCID.

背景:认知功能障碍是与社交技能相关的精神分裂症的主要症状。有报道称认知康复可以改善认知功能障碍。《精神分裂症认知能力简要评估-日本版》(BACS-J)常被用作评估认知康复效果的结果指标。然而,BACS-J综合评分的最小临床重要差异(MCID)尚未报道。因此,我们通过本研究计算BACS-J综合评分的初步MCID,确认回顾性数据收集和分析的可行性,为未来的大规模研究提供依据。方法:对接受认知康复治疗的精神分裂症患者病历进行回顾性调查。在认知康复开始和结束时收集BACS-J数据,并对认知康复结束时获得的临床总体印象改善(CGI-I)数据进行回顾性评估。为了使用基于分布的方法计算BACS-J综合评分中的MCID,将测量标准误差作为量表本身的一个特征来计算。采用锚定法计算MCID,确定CGI-I“最低改善”对应的BACS-J评分的平均变化。结果:本研究纳入28例患者,收集了所有患者的bac - j数据。11例患者完成CGI- i,其中3例根据其CGI评分显示“轻度改善”。基于分布的方法应用于28例患者的数据显示,BACS-J综合评分的MCID为0.735。由于样本量不足,最终没有采用基于锚定的方法。结论:本研究证实了CGI和BACS-J数据可以回顾性收集和分析。根据基于分布的方法,BACS-J综合评分增加约0.7可被认为具有临床意义。使用这两种计算方法的更大样本量的未来研究可以提供更准确的MCID。
{"title":"Minimal Clinically Important Difference in the Brief Assessment of Cognition in Schizophrenia-Japanese Version Composite Score: A Single-Center Preliminary Study.","authors":"Ryo Oya, Masaki Fujiwara, Yuto Yamada, Tsuyoshi Etoh, Seiji Katayama, Masatoshi Inagaki","doi":"10.33160/yam.2025.02.005","DOIUrl":"10.33160/yam.2025.02.005","url":null,"abstract":"<p><strong>Background: </strong>Cognitive dysfunction is a major symptom in schizophrenia associated with social skills. It has been reported that cognitive rehabilitation can improve cognitive dysfunction. The Brief Assessment of Cognition in Schizophrenia-Japanese version (BACS-J) is often used as an outcome measure to assess the effectiveness of cognitive rehabilitation. However, the minimal clinically important difference (MCID) in the BACS-J composite score has not been reported. Therefore, we conducted this study to calculate a preliminary MCID in the BACS-J composite score and confirm the feasibility of retrospective data collection and analysis for future large-scale studies.</p><p><strong>Methods: </strong>The medical records of patients with schizophrenia who underwent cognitive rehabilitation were retrospectively surveyed. BACS-J data were collected at the beginning and end of the cognitive rehabilitation, and Clinical Global Impression-Improvement (CGI-I) data obtained at the end of the cognitive rehabilitation were evaluated retrospectively. To calculate the MCID in the BACS-J composite score using distribution-based methods, the standard error of measurement was calculated as a characteristic of the scale itself. To calculate the MCID using anchor-based methods, the mean change in BACS-J score corresponding to \"minimally improved\" on the CGI-I was determined.</p><p><strong>Results: </strong>Twenty-eight patients were included in this study, and BACS-J data were collected from all patients. The CGI-I was completed by 11 patients, 3 of whom showed \"minimally improved\" according to their CGI scores. Distribution-based methods applied to the data of 28 patients revealed an MCID of 0.735 for the BACS-J composite score. Anchor-based methods were ultimately not applied because the sample size was insufficient.</p><p><strong>Conclusion: </strong>This study confirmed that CGI and BACS-J data can be collected and analyzed retrospectively. According to distribution-based methods, an increase of approximately 0.7 in the BACS-J composite score can be considered clinically meaningful. Future studies with larger sample sizes using both calculation methods could provide more accurate MCID.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 1","pages":"45-50"},"PeriodicalIF":0.9,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11831042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels. 中链甘油三酯通过增加β -羟基丁酸水平诱导动物模型的抗抑郁作用。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-23 eCollection Date: 2025-02-01 DOI: 10.33160/yam.2025.02.007
Akihiko Miura, Takehiko Yamanashi, Naofumi Kajitani, Saki Fukuda, Kyohei Tsunetomi, Ryoichi Matsuo, Tsuyoshi Nishiguchi, Shenghong Pu, Yumeto Nakada, Yukihiko Shirayama, Ken Watanabe, Koichi Kaneko, Masaaki Iwata

Background: Inflammation is believed to contribute to the pathophysiology of depression, with increased levels of inflammatory cytokines, such as interleukin-1β (IL-1β), observed in patients. Depression is also common in individuals with chronic inflammatory diseases. IL-1β disrupts synaptic transmission and reduces neurogenesis in the hippocampus, playing a crucial role in depression development. Our prior research found that stress activates microglia in the brain to produce IL-1β via the nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome. Additionally, β-hydroxybutyrate (BHB), an endogenous ketone body, alleviates stress-induced depression by inhibiting NLRP3 activation and IL-1β production. However, BHB's poor bioavailability limits its effectiveness. Medium-chain triglycerides (MCTs) can increase blood BHB levels, making them a potential treatment for stress-induced depression.

Methods: We tested MCT in two animal models: social defeat (SD) in mice and chronic unpredictable stress (CUS) in rats. MCT was orally administered to both groups to assess blood BHB levels. Behavioral tests, including the forced swim test (FST), were performed, and brain tissue was analyzed for IL-1β levels and spine density.

Results: MCT administration increased blood BHB levels 7-11 times within 1 hour. In the SD model, MCT significantly reduced immobility time in the FST, suggesting antidepressant effects. While the CUS model showed no significant change, a trend toward reduced immobility time was observed. MCT treatment also reduced stress-induced IL-1β levels in the rat hippocampus, although spine density remained unchanged.

Conclusion: MCT appears to alleviate stress-induced depression-like behaviors, likely through the suppression of IL-1β in the hippocampus. Owing to its ease of oral administration, MCT may offer a practical treatment for stress-related depression.

背景:炎症被认为有助于抑郁症的病理生理,在患者中观察到炎症细胞因子水平升高,如白细胞介素-1β (IL-1β)。抑郁症在慢性炎症性疾病患者中也很常见。IL-1β破坏突触传递并减少海马的神经发生,在抑郁症的发展中起着至关重要的作用。我们之前的研究发现,应激激活大脑中的小胶质细胞通过核苷酸结合寡聚化结构域样受体家族pyrin结构域3 (NLRP3)炎性体产生IL-1β。此外,内源性酮体β-羟基丁酸酯(BHB)通过抑制NLRP3的激活和IL-1β的产生来缓解应激性抑郁。然而,BHB较差的生物利用度限制了其有效性。中链甘油三酯(mct)可以增加血液中BHB的水平,使其成为治疗压力性抑郁症的潜在药物。方法:在小鼠社会失败(social defeat, SD)和大鼠慢性不可预测应激(chronic unpredictable stress, CUS)两种动物模型中测试MCT。两组均口服MCT以评估血液BHB水平。进行行为学测试,包括强迫游泳测试(FST),分析脑组织IL-1β水平和脊柱密度。结果:MCT在1小时内使血BHB水平升高7 ~ 11倍。在SD模型中,MCT显著减少了FST的静止时间,提示抗抑郁作用。虽然CUS模型没有明显变化,但观察到静止时间减少的趋势。MCT治疗也降低了应激诱导的大鼠海马IL-1β水平,尽管脊柱密度保持不变。结论:MCT似乎可以减轻应激诱导的抑郁样行为,可能是通过抑制海马中的IL-1β。由于易于口服,MCT可能为压力相关抑郁症提供实用的治疗方法。
{"title":"Medium-Chain Triglyceride Administration Induces Antidepressant Effects in Animal Models by Increasing Beta-Hydroxybutyrate Levels.","authors":"Akihiko Miura, Takehiko Yamanashi, Naofumi Kajitani, Saki Fukuda, Kyohei Tsunetomi, Ryoichi Matsuo, Tsuyoshi Nishiguchi, Shenghong Pu, Yumeto Nakada, Yukihiko Shirayama, Ken Watanabe, Koichi Kaneko, Masaaki Iwata","doi":"10.33160/yam.2025.02.007","DOIUrl":"10.33160/yam.2025.02.007","url":null,"abstract":"<p><strong>Background: </strong>Inflammation is believed to contribute to the pathophysiology of depression, with increased levels of inflammatory cytokines, such as interleukin-1β (IL-1β), observed in patients. Depression is also common in individuals with chronic inflammatory diseases. IL-1β disrupts synaptic transmission and reduces neurogenesis in the hippocampus, playing a crucial role in depression development. Our prior research found that stress activates microglia in the brain to produce IL-1β via the nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome. Additionally, β-hydroxybutyrate (BHB), an endogenous ketone body, alleviates stress-induced depression by inhibiting NLRP3 activation and IL-1β production. However, BHB's poor bioavailability limits its effectiveness. Medium-chain triglycerides (MCTs) can increase blood BHB levels, making them a potential treatment for stress-induced depression.</p><p><strong>Methods: </strong>We tested MCT in two animal models: social defeat (SD) in mice and chronic unpredictable stress (CUS) in rats. MCT was orally administered to both groups to assess blood BHB levels. Behavioral tests, including the forced swim test (FST), were performed, and brain tissue was analyzed for IL-1β levels and spine density.</p><p><strong>Results: </strong>MCT administration increased blood BHB levels 7-11 times within 1 hour. In the SD model, MCT significantly reduced immobility time in the FST, suggesting antidepressant effects. While the CUS model showed no significant change, a trend toward reduced immobility time was observed. MCT treatment also reduced stress-induced IL-1β levels in the rat hippocampus, although spine density remained unchanged.</p><p><strong>Conclusion: </strong>MCT appears to alleviate stress-induced depression-like behaviors, likely through the suppression of IL-1β in the hippocampus. Owing to its ease of oral administration, MCT may offer a practical treatment for stress-related depression.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 1","pages":"58-67"},"PeriodicalIF":0.9,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11831044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential Efficacy of Inflammatory Response Markers for the Detection of Ovarian Cancer in Patients with Endometrioma. 炎症反应标记物对子宫内膜瘤患者卵巢癌检测的潜在功效
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-23 eCollection Date: 2025-02-01 DOI: 10.33160/yam.2025.02.006
Yuki Iida, Shinya Sato, Koji Yamamoto, Masayo Okawa, Kohei Hikino, Mayumi Sawada, Hiroaki Komatsu, Fuminori Taniguchi

Background: This study evaluated the effectiveness of preoperative inflammatory response markers in distinguishing clear cell carcinoma (CCC) and endometrioid carcinoma (EC) from ovarian endometrioma.

Methods: Patients with stage I ovarian cancer with histology CCC/EC or endometrioma who underwent surgery at our institution between 2010 and 2021 were included. Preoperative inflammatory response markers evaluated were white blood cell count, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, D-dimer, neutrophil/lymphocyte ratio (NLR), platelet count/lymphocyte ratio (PLR), and systemic immune-inflammation index (SII). The tumor markers CA125 and CA19-9 were analyzed. The median values of these markers were compared between the CCC/EC and the endometrioma groups. The areas under the curve (AUC) in Receiver Operating Characteristic analysis were compared.

Results: Fifty patients with stage I CCC/EC and 247 patients with endometrioma were included in the study. Inflammatory response markers were significantly higher in CCC/EC cases than in endometrioma cases (P < 0.01). Tumor markers demonstrated higher specificity than inflammatory response markers. The AUCs of CRP, ESR, D-dimer, NLR, and SII were significantly higher than those of CA125 and CA19-9 (P < 0.01). The values of NLR, PLR, and SII in four cases of ovarian cancer with preoperative suspected endometrioma were higher than the cut-off value.

Conclusion: Inflammatory response markers may be useful for the detection of stage I ovarian cancer. Notably, the NLR or SII, calculated using a complete blood count, appears particularly efficient. Combining tumor and inflammatory response markers may enhance diagnostic accuracy in distinguishing ovarian cancer from endometrioma.

背景:本研究评估术前炎症反应标志物在区分卵巢子宫内膜异位瘤中透明细胞癌(CCC)和子宫内膜样癌(EC)的有效性。方法:纳入2010年至2021年间在我院接受手术的组织学为CCC/EC或子宫内膜异位瘤的I期卵巢癌患者。术前评估炎症反应指标为白细胞计数、c反应蛋白(CRP)、红细胞沉降率(ESR)、纤维蛋白原、d -二聚体、中性粒细胞/淋巴细胞比值(NLR)、血小板计数/淋巴细胞比值(PLR)和全身免疫炎症指数(SII)。分析肿瘤标志物CA125和CA19-9。比较CCC/EC组和子宫内膜异位瘤组这些标志物的中位数。比较了受试者工作特性分析的曲线下面积(AUC)。结果:50例I期CCC/EC患者和247例子宫内膜异位瘤患者纳入研究。炎症反应指标在CCC/EC组明显高于子宫内膜异位瘤组(P < 0.01)。肿瘤标志物比炎症反应标志物具有更高的特异性。CRP、ESR、d -二聚体、NLR、SII的auc均显著高于CA125、CA19-9 (P < 0.01)。4例术前怀疑子宫内膜异位瘤的卵巢癌患者NLR、PLR、SII值均高于临界值。结论:炎症反应标志物可用于ⅰ期卵巢癌的检测。值得注意的是,使用全血细胞计数计算的NLR或SII似乎特别有效。结合肿瘤和炎症反应标志物可提高卵巢癌和子宫内膜瘤的诊断准确性。
{"title":"Potential Efficacy of Inflammatory Response Markers for the Detection of Ovarian Cancer in Patients with Endometrioma.","authors":"Yuki Iida, Shinya Sato, Koji Yamamoto, Masayo Okawa, Kohei Hikino, Mayumi Sawada, Hiroaki Komatsu, Fuminori Taniguchi","doi":"10.33160/yam.2025.02.006","DOIUrl":"10.33160/yam.2025.02.006","url":null,"abstract":"<p><strong>Background: </strong>This study evaluated the effectiveness of preoperative inflammatory response markers in distinguishing clear cell carcinoma (CCC) and endometrioid carcinoma (EC) from ovarian endometrioma.</p><p><strong>Methods: </strong>Patients with stage I ovarian cancer with histology CCC/EC or endometrioma who underwent surgery at our institution between 2010 and 2021 were included. Preoperative inflammatory response markers evaluated were white blood cell count, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, D-dimer, neutrophil/lymphocyte ratio (NLR), platelet count/lymphocyte ratio (PLR), and systemic immune-inflammation index (SII). The tumor markers CA125 and CA19-9 were analyzed. The median values of these markers were compared between the CCC/EC and the endometrioma groups. The areas under the curve (AUC) in Receiver Operating Characteristic analysis were compared.</p><p><strong>Results: </strong>Fifty patients with stage I CCC/EC and 247 patients with endometrioma were included in the study. Inflammatory response markers were significantly higher in CCC/EC cases than in endometrioma cases (<i>P</i> < 0.01). Tumor markers demonstrated higher specificity than inflammatory response markers. The AUCs of CRP, ESR, D-dimer, NLR, and SII were significantly higher than those of CA125 and CA19-9 (<i>P</i> < 0.01). The values of NLR, PLR, and SII in four cases of ovarian cancer with preoperative suspected endometrioma were higher than the cut-off value.</p><p><strong>Conclusion: </strong>Inflammatory response markers may be useful for the detection of stage I ovarian cancer. Notably, the NLR or SII, calculated using a complete blood count, appears particularly efficient. Combining tumor and inflammatory response markers may enhance diagnostic accuracy in distinguishing ovarian cancer from endometrioma.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 1","pages":"51-57"},"PeriodicalIF":0.9,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11831038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding of Thirst in Medical Science. 医学对口渴的认识
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-18 eCollection Date: 2025-02-01 DOI: 10.33160/yam.2025.02.001
Takeshi Y Hiyama

Thirst is fundamentally considered as a physiological function developed to maintain the homeostasis of body fluids. However, we occasionally experience thirst in situations that are not necessarily related to the maintenance of bodily fluid homeostasis. Because the only method available had been to quantify the degree of thirst using psychological indices, thirst research had made little progress until very recently. To quantitatively analyze thirst, it is necessary to elucidate the nature of the brain's "thirst center," which is believed to become active in response to thirst. Textbooks of physiology often refer to the "thirst center" in the hypothalamus, which is considered to sense the osmotic pressure of body fluids. However, they did not specify the location of this center in the hypothalamus. Furthermore, the existence of the so-called "osmotic pressure sensors" has yet to be confirmed. However, recently, a series of findings have been published that delve into the true nature of the thirst center. These advancements have been achieved using several new techniques, including the real-time monitoring of neural activities related to thirst regulation within the brains of experimental animals. At least at the animal level, recent advancements in experimental techniques have made it possible to objectively quantify the intensity of thirst as a physiological response. In this review article, the history of our research is presented and latest developments in thirst research are presented.

口渴从根本上被认为是一种维持体液平衡的生理功能。然而,我们偶尔会在与体液平衡维持无关的情况下感到口渴。由于唯一可用的方法是使用心理指标来量化口渴的程度,直到最近,对口渴的研究才取得了一些进展。为了定量分析口渴,有必要阐明大脑“口渴中心”的性质,该中心被认为在口渴时变得活跃。生理学教科书经常提到下丘脑中的“口渴中心”,它被认为是感知体液的渗透压。然而,他们没有具体说明这个中心在下丘脑的位置。此外,所谓的“渗透压传感器”的存在还有待证实。然而,最近发表的一系列研究结果深入研究了口渴中枢的真实本质。这些进步是通过几种新技术实现的,包括对实验动物大脑中与口渴调节相关的神经活动的实时监测。至少在动物水平上,最近实验技术的进步使得客观地量化口渴的强度作为一种生理反应成为可能。在这篇综述文章中,介绍了我们的研究历史和口渴研究的最新进展。
{"title":"Understanding of Thirst in Medical Science.","authors":"Takeshi Y Hiyama","doi":"10.33160/yam.2025.02.001","DOIUrl":"10.33160/yam.2025.02.001","url":null,"abstract":"<p><p>Thirst is fundamentally considered as a physiological function developed to maintain the homeostasis of body fluids. However, we occasionally experience thirst in situations that are not necessarily related to the maintenance of bodily fluid homeostasis. Because the only method available had been to quantify the degree of thirst using psychological indices, thirst research had made little progress until very recently. To quantitatively analyze thirst, it is necessary to elucidate the nature of the brain's \"thirst center,\" which is believed to become active in response to thirst. Textbooks of physiology often refer to the \"thirst center\" in the hypothalamus, which is considered to sense the osmotic pressure of body fluids. However, they did not specify the location of this center in the hypothalamus. Furthermore, the existence of the so-called \"osmotic pressure sensors\" has yet to be confirmed. However, recently, a series of findings have been published that delve into the true nature of the thirst center. These advancements have been achieved using several new techniques, including the real-time monitoring of neural activities related to thirst regulation within the brains of experimental animals. At least at the animal level, recent advancements in experimental techniques have made it possible to objectively quantify the intensity of thirst as a physiological response. In this review article, the history of our research is presented and latest developments in thirst research are presented.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 1","pages":"1-11"},"PeriodicalIF":0.9,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11831041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the Survivals and Adverse Events for Localized High-Risk Prostate Cancer Treated with Intensity-Modulated Radiotherapy Plus Androgen Deprivation and Trimodality Therapy, Including Low-Dose Iodine-125 Brachytherapy and External Beam Radiotherapy Plus Androgen Deprivation. 调强放疗加雄激素剥夺与低剂量碘125近距离放疗和外束放疗加雄激素剥夺三段式治疗局部高危前列腺癌的生存和不良事件比较
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-06 eCollection Date: 2025-02-01 DOI: 10.33160/yam.2025.02.002
Yutaka Kitagawa, Kenji Yoshida, Yuuki Takeuchi, Tomohiko Tanino, Hiromi Sakaguchi, Ryutaro Shimizu, Noriya Yamaguchi, Shuichi Morizane, Atsushi Takenaka

Background: To evaluate and compare the survivals and radiotherapy-induced adverse events (AEs) of intensity-modulated radiotherapy (IMRT) with androgen deprivation therapy (ADT) and trimodality therapy, including low-dose iodine-125 brachytherapy, external beam radiotherapy, and ADT, for high-risk localized prostate cancer (LPC).

Methods: High-risk patients with LPC at T stage ≥ 3a, Gleason score ≥ 8, and initial prostate-specific antigen ≥ 20.0 ng/mL treated between 2010 and 2021 were retrospectively evaluated. All the patients were treated with IMRT plus ADT or trimodality therapy. In both groups, ADT was initiated 6 months before and continued for 2 years after radiotherapy. Survival and acute and late radiation-induced AEs were evaluated and compared.

Results: Two hundred and thirty-eight patients were treated with IMRT, and 91 underwent trimodality. Five- and 7-year biochemical-clinical failure-free survival (BCFFS) rates in the IMRT/trimodality group were 94.9/96.2, and 91.8/91.5%, respectively (P = 0.511). Stratified by 1-2/3 factors, 5- and 7-year BCFFS rates in the IMRT groups were 95.8/91.8, and 95.8/75.6%, respectively (P = 0.009). Five and 7-year BCFFS rates in the trimodality group were 96.8/94.1, and 91.4/94.1%, respectively (P = 0.995). The cumulative 3-/5-year incidence of late genitourinary AEs in the IMRT/trimodality group was 7.3/8.4, and 15.5/16.9%, respectively (P = 0.037), and the cumulative 3-/5-year incidence of late gastrointestinal AEs was 2.2/3.4, and 11.0/12.2%, respectively (P = 0.001). Thirty patients (9.1%) could not complete long-term ADT.

Conclusion: Treatment results of both IMRT and trimodality were considered to be good, and our results also indicated that the long-term survival of unfavorable high-risk patients with LPC who had three risk factors was poor in the IMRT group. Further treatment experience of both modalities must be accumulated with more appropriate patient allocations.

背景:评估和比较调强放疗(IMRT)与雄激素剥夺治疗(ADT)和三模式治疗(包括低剂量碘-125近距离放疗、外束放疗和ADT)治疗高危局限性前列腺癌(LPC)的生存率和放疗引起的不良事件(ae)。方法:回顾性分析2010 ~ 2021年治疗的T期≥3a、Gleason评分≥8分、初始前列腺特异性抗原≥20.0 ng/mL的高危LPC患者。所有患者均采用IMRT + ADT或三联疗法治疗。两组患者均于放疗前6个月开始ADT治疗,放疗后持续2年。评估和比较生存和急性和晚期辐射诱发的ae。结果:238例患者接受了IMRT治疗,91例患者接受了三联治疗。IMRT/三模式组5年和7年生化-临床无失败生存率(BCFFS)分别为94.9/96.2和91.8/91.5% (P = 0.511)。按1-2/3因素分层,IMRT组5年、7年BCFFS率分别为95.8/91.8、95.8/75.6% (P = 0.009)。三模态组5年、7年BCFFS率分别为96.8/94.1、91.4/94.1% (P = 0.995)。IMRT/三模态组晚期泌尿生殖系统ae累积3/ 5年发生率分别为7.3/8.4、15.5/16.9% (P = 0.037),晚期胃肠道ae累积3/ 5年发生率分别为2.2/3.4、11.0/12.2% (P = 0.001)。30例(9.1%)患者不能完成长期ADT治疗。结论:IMRT和三联疗法治疗效果均较好,同时我们的研究结果也表明,同时存在三种危险因素的LPC不良高危患者,IMRT组的长期生存率较差。两种方式的进一步治疗经验必须通过更适当的患者分配来积累。
{"title":"Comparison of the Survivals and Adverse Events for Localized High-Risk Prostate Cancer Treated with Intensity-Modulated Radiotherapy Plus Androgen Deprivation and Trimodality Therapy, Including Low-Dose Iodine-125 Brachytherapy and External Beam Radiotherapy Plus Androgen Deprivation.","authors":"Yutaka Kitagawa, Kenji Yoshida, Yuuki Takeuchi, Tomohiko Tanino, Hiromi Sakaguchi, Ryutaro Shimizu, Noriya Yamaguchi, Shuichi Morizane, Atsushi Takenaka","doi":"10.33160/yam.2025.02.002","DOIUrl":"10.33160/yam.2025.02.002","url":null,"abstract":"<p><strong>Background: </strong>To evaluate and compare the survivals and radiotherapy-induced adverse events (AEs) of intensity-modulated radiotherapy (IMRT) with androgen deprivation therapy (ADT) and trimodality therapy, including low-dose iodine-125 brachytherapy, external beam radiotherapy, and ADT, for high-risk localized prostate cancer (LPC).</p><p><strong>Methods: </strong>High-risk patients with LPC at T stage ≥ 3a, Gleason score ≥ 8, and initial prostate-specific antigen ≥ 20.0 ng/mL treated between 2010 and 2021 were retrospectively evaluated. All the patients were treated with IMRT plus ADT or trimodality therapy. In both groups, ADT was initiated 6 months before and continued for 2 years after radiotherapy. Survival and acute and late radiation-induced AEs were evaluated and compared.</p><p><strong>Results: </strong>Two hundred and thirty-eight patients were treated with IMRT, and 91 underwent trimodality. Five- and 7-year biochemical-clinical failure-free survival (BCFFS) rates in the IMRT/trimodality group were 94.9/96.2, and 91.8/91.5%, respectively (<i>P</i> = 0.511). Stratified by 1-2/3 factors, 5- and 7-year BCFFS rates in the IMRT groups were 95.8/91.8, and 95.8/75.6%, respectively (<i>P</i> = 0.009). Five and 7-year BCFFS rates in the trimodality group were 96.8/94.1, and 91.4/94.1%, respectively (<i>P</i> = 0.995). The cumulative 3-/5-year incidence of late genitourinary AEs in the IMRT/trimodality group was 7.3/8.4, and 15.5/16.9%, respectively (<i>P</i> = 0.037), and the cumulative 3-/5-year incidence of late gastrointestinal AEs was 2.2/3.4, and 11.0/12.2%, respectively (<i>P</i> = 0.001). Thirty patients (9.1%) could not complete long-term ADT.</p><p><strong>Conclusion: </strong>Treatment results of both IMRT and trimodality were considered to be good, and our results also indicated that the long-term survival of unfavorable high-risk patients with LPC who had three risk factors was poor in the IMRT group. Further treatment experience of both modalities must be accumulated with more appropriate patient allocations.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 1","pages":"12-21"},"PeriodicalIF":0.9,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11831037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of an Instructional Design-Based Self-Management Program for Patients with Knee Osteoarthritis. 基于教学设计的膝骨关节炎患者自我管理方案的有效性。
IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-01-06 eCollection Date: 2025-02-01 DOI: 10.33160/yam.2025.02.003
Chika Tanimura, Yasuko Tokushima, Junko Yoshimura, Masayuki Miyoshi, Hiromi Matsumoto, Tetsuji Morita, Akihiko Matsumoto, Yoshifumi Ogura, Masaru Nezu, Hiroshi Hagino, Yuka Matsumoto, Hisashi Noma, Yoshimi Noguchi, Keiko Oba, Yoshiyuki Hasegawa

Background: In recent years, various psychological interventions have garnered attention as effective support methods to promote self-management and comprehensively understand those with physical and psychological problems associated with knee pain. The purpose of this study was to implement an instructional design (ID) based self-management program for outpatients diagnosed with KOA and to verify the effectiveness of the program.

Methods: In this single-arm uncontrolled before‒after comparative intervention study, 41 subjects diagnosed with symptomatic knee osteoarthritis participated in an intervention program. Their pain, physical function, self-efficacy, self-care agency, and daily life difficulties were evaluated. A mixed-effects model was employed to examine the changes in each outcome from baseline to immediately before and after the intervention, and after one, three, and six months.

Results: "Pain at the beginning of walking," "pain from standing to sitting position," and "pain after long-distance walking" reduced significantly immediately after the intervention and after one month. "Pain when climbing stairs" reduced significantly immediately after the intervention and after one, three, and six months. The sit-to-stand test showed significant improvement from baseline to immediately after and one, three, and six months after the intervention. Self-care agency scores improved significantly immediately after the intervention and after one and six months.

Conclusion: The intervention program effectively improved physical function, self-care agency, and self-efficacy, and reduced pain from one to six months. Innovation: This program could lead to an increase in the healthy life expectancy of the older adults.

背景:近年来,各种心理干预作为促进自我管理和全面了解膝关节疼痛相关生理和心理问题的有效支持方法受到关注。摘要本研究的目的是实施一套基于教学设计(ID)的KOA门诊患者自我管理方案,并验证该方案的有效性。方法:在这项单臂非对照干预前后对比研究中,41名诊断为症状性膝骨关节炎的受试者参加了干预计划。评估患者的疼痛、身体功能、自我效能、自我照顾能力和日常生活困难。采用混合效应模型来检查从基线到立即干预前后,以及1个月,3个月和6个月后的每个结果的变化。结果:“开始行走时的疼痛”、“从站立到坐姿的疼痛”和“长距离行走后的疼痛”在干预后和一个月后均显著减少。“爬楼梯时的疼痛”在干预后、1个月、3个月和6个月后立即显著减少。从基线到干预后立即以及干预后1个月、3个月和6个月,坐到站的测试显示出显著的改善。自我照顾能力得分在干预后、1个月和6个月后立即显著提高。结论:干预方案可有效改善患者1 ~ 6个月的身体功能、自理能力和自我效能感,减轻疼痛。创新:该项目可延长老年人的健康预期寿命。
{"title":"Effectiveness of an Instructional Design-Based Self-Management Program for Patients with Knee Osteoarthritis.","authors":"Chika Tanimura, Yasuko Tokushima, Junko Yoshimura, Masayuki Miyoshi, Hiromi Matsumoto, Tetsuji Morita, Akihiko Matsumoto, Yoshifumi Ogura, Masaru Nezu, Hiroshi Hagino, Yuka Matsumoto, Hisashi Noma, Yoshimi Noguchi, Keiko Oba, Yoshiyuki Hasegawa","doi":"10.33160/yam.2025.02.003","DOIUrl":"10.33160/yam.2025.02.003","url":null,"abstract":"<p><strong>Background: </strong>In recent years, various psychological interventions have garnered attention as effective support methods to promote self-management and comprehensively understand those with physical and psychological problems associated with knee pain. The purpose of this study was to implement an instructional design (ID) based self-management program for outpatients diagnosed with KOA and to verify the effectiveness of the program.</p><p><strong>Methods: </strong>In this single-arm uncontrolled before‒after comparative intervention study, 41 subjects diagnosed with symptomatic knee osteoarthritis participated in an intervention program. Their pain, physical function, self-efficacy, self-care agency, and daily life difficulties were evaluated. A mixed-effects model was employed to examine the changes in each outcome from baseline to immediately before and after the intervention, and after one, three, and six months.</p><p><strong>Results: </strong>\"Pain at the beginning of walking,\" \"pain from standing to sitting position,\" and \"pain after long-distance walking\" reduced significantly immediately after the intervention and after one month. \"Pain when climbing stairs\" reduced significantly immediately after the intervention and after one, three, and six months. The sit-to-stand test showed significant improvement from baseline to immediately after and one, three, and six months after the intervention. Self-care agency scores improved significantly immediately after the intervention and after one and six months.</p><p><strong>Conclusion: </strong>The intervention program effectively improved physical function, self-care agency, and self-efficacy, and reduced pain from one to six months. <i>Innovation</i>: This program could lead to an increase in the healthy life expectancy of the older adults.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"68 1","pages":"22-33"},"PeriodicalIF":0.9,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11831039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Yonago acta medica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1